mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
8e-10 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-09 |
mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-09 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-09 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-09 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-09 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-09 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-09 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-09 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
9e-09 |